Open AccessProgastrin-Releasing Peptide Precursor and Neuron-Specific Enolase Predict the Efficacy of First-Line Treatment with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Among Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations
Author(s) -
Juanjuan Dong,
Sihao Tong,
Xianglin Shi,
Chao Wang,
Xianmin Xiao,
Wenping Ji,
Yimian Sun
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s285121
Subject(s) - medicine , lung cancer , oncology , epidermal growth factor receptor , enolase , tyrosine kinase inhibitor , proportional hazards model , progression free survival , tyrosine kinase , cancer research , cancer , immunohistochemistry , chemotherapy , receptor